In spite of the previous extensive studies on Xid mice and human XLA patients, however, our study revealed that the effects of BTK inhibition on the production of proinflammatory cytokines such as IL-6 and TNF-α from macrophages were limited (Fig. 1e). The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.